Changxun Fang. Pioneers of Allelopathy: Wenxiong Lin

2021 ◽  
Vol 53 (1) ◽  
pp. 1-14
Author(s):  
Changxun Fang
Keyword(s):  
Medicinal Plants ◽  
Technological Progress ◽  
Molecular Ecology ◽  
Continuous Cropping ◽  
Inhibitory Effects ◽  
Outstanding Achievement ◽  
Soil Sickness ◽  
Chinese Medicinal Plants ◽  
Ecological Mechanism ◽  
Continuous Monoculture

Wenxiong Lin did research for > 30 years in plant molecular ecology and agro-ecology, rice allelopathy and continuous monoculture problems/soil sickness of Chinese medicinal plants. His 20 Patents and most publications (about 100) have focussed on (i). Gene regulation of allelochemicals biosynthesis in allelopathic rice, (ii). allelopathic inhibitory effects on weeds, (iii). continuous monoculture problems/soil sickness in medicinal plants and (iv). the influence of allelochemicals and monoculture practice on the rhizospheric micro-environment. He helped in development of microbial fertilizer to alleviate the autotoxicity problem in continuous cropping of Radix pseudostellariae and Rehmannia glutinosa, etc. He had been the President of Asian Allelopathy Society, and got the outstanding achievement from the platform of International Allelopathy Foundation. His student, Dr. Changxun Fang got Rice Award and Grodzinsky Award respectively in the 6th and 8th World Congress of International Allelopathy Society. His elucidation of the molecular ecological mechanism of rice allelopathy was awarded the II Class Prize of Fujian Provincial Scientific and Technological Progress Award in 2007. His researches to find the mechanism of development of continuous cropping obstacle/soil sickness in R. pseudostellariae and its remedy was awarded the I Class Prize of Fujian Provincial Scientific and Technological Progress Award in 2020.

scholarly journals Chinese Medicinal Plants from the Pen Ts'ao Kang Mu, AD 1596

Nature ◽  
1936 ◽  
Vol 138 (3490) ◽  
pp. 484-484
Author(s):  
T. A. H.
Keyword(s):  
Medicinal Plants ◽  
Chinese Medicinal Plants

scholarly journals Sickle hemoglobin polymerization and antisickling medicinal plants

2021 ◽  
Vol 10 (2) ◽  
pp. 126-133
Author(s):  
Franklyn O. Ohiagu ◽  
◽  
Paul C. Chikezie ◽  
Chinwendu M. Chikezie ◽  
◽  
...  
Keyword(s):  
Medicinal Plants ◽  
Transplant Rejection ◽  
Gene Replacement ◽  
New Drugs ◽  
Cell Disease ◽  
Inhibitory Effects ◽  
Therapeutic Approaches ◽  
Sickle Hemoglobin ◽  
Adverse Health Effects ◽  
Gene Replacement Therapy

Sickle cell disease (SCD) is a dilapidating disorder that is associated with organ destruction and decreased life expectancy. Therapeutic remedies that lead to fundamental cure of SCD such as, bone marrow and stem cell transplantations, as well as gene replacement therapy, are very costly and unaffordable to the disease sufferers in developing countries. In regions where these therapeutic approaches are possible, there are also limitations such as immunologic transplant rejection, difficulty in prognosis, difficulty in obtaining a suitable donor, end-organ dysfunction, and adverse health effects, especially among the older sufferers of this disease. The eagerness of researchers to develop new drugs for the amelioration of the crisis associated with SCD and a possible cure of the disease has led to the discovery of biomolecular agents that inhibit the mechanisms of HbS polymerization as well as medicinal plants with antisickling potentials. The antisickling potency of medicinal plants should be harnessed through research funding and efforts geared towards the discovery of molecules in such plants with HbS polymerization inhibitory effects.

Sign in / Sign up

Export Citation Format

Share Document